The FDA is concerned that unsupported claims about gene-drug links could be dangerous, spurring patients to start, stop, or switch…
The effect of oral androgen signaling inhibitor therapies on patients with pre-existing cardiovascular disease may increase the risk of death.…
The FDA is issuing an update regarding the ongoing efforts to resolve safety issues with ARB medications. — Read on…
The FDA is issuing an update regarding the ongoing efforts to resolve safety issues with ARB medications. — Read on…
Selinexor with dexamethasone effective in more than one-quarter of patients with multiple myeloma during a clinical trial. — Read on…
Eli Lilly’s ixekizumab (Taltz) injection 80 mg/mL is now approved for the treatment of active ankylosing spondylitis. — Read on…
FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease — Read on www.fda.gov/news-events/press-announcements/fda-approves-new-add-drug-treat-episodes-adults-parkinsons-disease
Drug Trials Snapshots: PRETOMANID — Read on www.fda.gov/drugs/development-approval-process-drugs/drug-trials-snapshots-pretomanid
Evidence of infection with an enterovirus was found in about 80% of people with the rare but serious condition called…
Patients with progressive multiple sclerosis who were placed on the Wahls diet, which is high in fruits and vegetables, found…